Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

February 14, 2026

Study Completion Date

February 28, 2026

Conditions
Intrauterine Adhesion
Interventions
DRUG

Heparin solution

3 ml saline solution containing 5000 IU heparin.

DRUG

Anti-adhesion barrier gel

2 ml biodegradable barrier gel containing sodium hyaluronate (10 mg/ml), sodium chloride (8.5 mg/ml), disodium hydrogen phosphate (0.34mg/ml), sodium dihydrogen phosphate (0.14 mg/ml) and water for injection (QS to weight).

Trial Locations (2)

1330

RECRUITING

Nadezhda Women's Health Hospital, Sofia

1373

RECRUITING

Nadezhda Women's Health Hospital, Sofia

All Listed Sponsors
lead

Nadezhda Women's Health Hospital

OTHER